Skip to content

Form 4 filed by Bazemore Robert B

Bazemore Robert B filed this Form 4 on AKTX (Akari Therapeutics Plc) with 8 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-16 21:20:11 UTC.

Accession
0001493152-26-047455
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: AKTX · Akari Therapeutics Plc (CIK 1541157)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
American Depositary Shares representing Ordinary Shares 2026-08-18A granted+13,100$7.89914,216D
American Depositary Shares representing Ordinary Shares 2026-10-05A granted+4,677$7.89918,893D
American Depositary Shares representing Ordinary Shares 2026-10-14M exercised+773$0.000419,666D
American Depositary Shares representing Ordinary Shares 2026-10-14M exercised+3,093$0.000422,759D
Stock Option (Right to Buy) derivative2026-08-18A granted+45,000$045,000D
Stock Option (Right to Buy) derivative2026-08-18A granted+15,000$015,000D
Pre-Funded Warrant to Purchase ADSs derivative2026-10-14M exercised-773$16.160D
Pre-Funded Warrant to Purchase ADSs derivative2026-10-14M exercised-3,093$16.160D